Company facts
- Headquarters
- Anaheim, California
- Most recent report
- 8-K, filed Sep 4, 2026
- Filings on record
- 499 filings
- On EDGAR
- CIK 1443863
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 81
News 8 of 141
Prospectuses and Registrations 8 of 11
- S-1 Registration statement for an offering Feb 14, 2019
- S-1/A Registration statement for an offering, amended Sep 5, 2018
- S-1 Registration statement for an offering Aug 24, 2018
- S-8 POS Post-effective amendment to an employee plan registration Jan 7, 2015
- S-8 POS Post-effective amendment to an employee plan registration Nov 19, 2014
- S-8 Registration statement for an employee plan Nov 19, 2014
- S-8 Registration statement for an employee plan Jan 10, 2014
- S-8 Registration statement for an employee plan Dec 18, 2012
Ownership 8 of 195
- 4 Insider reported a trade Jan 31, 2025
- 4 Insider reported a trade Jan 31, 2025
- 4 Insider reported a trade Jul 10, 2024
- 4 Insider reported a trade Jul 8, 2024
- 4 Insider reported a trade Jul 8, 2024
- 4 Insider reported a trade Jun 3, 2024
- 4 Insider reported a trade May 1, 2024
- 4 Insider reported a trade Apr 5, 2024
Other 8 of 71
- RW Dec 9, 2019
- NT 10-K Notice that an annual report will be late Apr 2, 2019
- EFFECT Notice that a registration became effective Sep 12, 2018
- CORRESP Reply to SEC staff Sep 7, 2018
- UPLOAD Comment letter from SEC staff Aug 30, 2018
- NT 10-Q Notice that a quarterly report will be late May 15, 2018
- UPLOAD Comment letter from SEC staff Apr 17, 2018
- DEF 14C Apr 10, 2018
Everything here comes from BioCorRx Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.